Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Atea Pharmaceuticals, Inc. (AVIR) had Return on Equity of -10.20% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-37.16M |
|
-- |
|
-- |
|
$41.34M |
|
$-41.34M |
|
$4.39M |
|
$-36.95M |
|
$-36.95M |
|
$-37.16M |
|
$-37.16M |
|
$-37.16M |
|
$-37.16M |
|
$-41.34M |
|
$-42.56M |
|
83.75M |
|
83.75M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$385.60M |
|
$0.67M |
|
$6.00M |
|
$391.61M |
|
$20.12M |
|
-- |
|
$7.07M |
|
$27.19M |
|
$364.42M |
|
$364.42M |
|
$364.42M |
|
81.14M |
|
| Cash Flow Statement Financials | |
$-63.43M |
|
$100.90M |
|
$-14.44M |
|
$64.70M |
|
$87.72M |
|
$23.02M |
|
$11.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-286.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-10.20% |
-10.20% |
|
-9.49% |
|
-10.20% |
|
$4.49 |
|
$-3.42 |
|
$-0.76 |
|